Switch theme
Sign up to access all valuation multiples
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
1987
159
LTM Revenue $86.8M
LTM EBITDA $17.9M
$966M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BioLife Solutions has a last 12-month revenue of $86.8M and a last 12-month EBITDA of $17.9M.
In the most recent fiscal year, BioLife Solutions achieved revenue of $82.3M and an EBITDA of $1.5M.
BioLife Solutions expects next 12-month revenue of XXX and NTM EBITDA of XXX
See BioLife Solutions valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $143M | $82.3M | XXX | XXX | XXX |
| Gross Profit | $53.8M | $46.8M | XXX | XXX | XXX |
| Gross Margin | 38% | 57% | XXX | XXX | XXX |
| EBITDA | -$45.2M | $1.5M | XXX | XXX | XXX |
| EBITDA Margin | -32% | 2% | XXX | XXX | XXX |
| Net Profit | -$140M | -$66.4M | XXX | XXX | XXX |
| Net Margin | -98% | -81% | XXX | XXX | XXX |
| Net Debt | $6.2M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 23, 2025, BioLife Solutions's stock price is $22.
BioLife Solutions has current market cap of $1.0B, and EV of $966M.
See BioLife Solutions trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $966M | $1.0B | XXX | XXX | XXX | XXX | $-0.21 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 23, 2025, BioLife Solutions has market cap of $1.0B and EV of $966M.
BioLife Solutions's trades at 11.1x LTM EV/Revenue multiple, and 54.1x LTM EBITDA.
Analysts estimate BioLife Solutions's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for BioLife Solutions and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $966M | XXX | XXX | XXX |
| EV/Revenue | 11.7x | XXX | XXX | XXX |
| EV/EBITDA | 630.8x | XXX | XXX | XXX |
| P/E | -51.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 197.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBioLife Solutions's NTM/LTM revenue growth is 18%
BioLife Solutions's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, BioLife Solutions's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate BioLife Solutions's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for BioLife Solutions and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -43% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -103% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 20% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 49% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 74% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Schott Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Fresenius Medical Care | XXX | XXX | XXX | XXX | XXX | XXX |
| Fresenius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BioLife Solutions acquired XXX companies to date.
Last acquisition by BioLife Solutions was XXXXXXXX, XXXXX XXXXX XXXXXX . BioLife Solutions acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was BioLife Solutions founded? | BioLife Solutions was founded in 1987. |
| Where is BioLife Solutions headquartered? | BioLife Solutions is headquartered in United States of America. |
| How many employees does BioLife Solutions have? | As of today, BioLife Solutions has 159 employees. |
| Who is the CEO of BioLife Solutions? | BioLife Solutions's CEO is Mr. Roderick De Greef. |
| Is BioLife Solutions publicy listed? | Yes, BioLife Solutions is a public company listed on NAS. |
| What is the stock symbol of BioLife Solutions? | BioLife Solutions trades under BLFS ticker. |
| When did BioLife Solutions go public? | BioLife Solutions went public in 1992. |
| Who are competitors of BioLife Solutions? | Similar companies to BioLife Solutions include e.g. Ansell, Polymed, Schott Pharma, Fresenius Medical Care. |
| What is the current market cap of BioLife Solutions? | BioLife Solutions's current market cap is $1.0B |
| What is the current revenue of BioLife Solutions? | BioLife Solutions's last 12-month revenue is $86.8M. |
| What is the current EBITDA of BioLife Solutions? | BioLife Solutions's last 12-month EBITDA is $17.9M. |
| What is the current EV/Revenue multiple of BioLife Solutions? | Current revenue multiple of BioLife Solutions is 11.1x. |
| What is the current EV/EBITDA multiple of BioLife Solutions? | Current EBITDA multiple of BioLife Solutions is 54.1x. |
| What is the current revenue growth of BioLife Solutions? | BioLife Solutions revenue growth between 2023 and 2024 was -43%. |
| Is BioLife Solutions profitable? | Yes, BioLife Solutions is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
